GelStat Corporation (“GelStat” or “Company”) is dedicated to providing safe and effective over-the-counter (OTC) treatments for pain and inflammation. GelStat's first product, GelStat Migraine, is sold through retail chain stores, independent retailers and pharmacies, and direct to consumer channels. The Company also has a suite of additional, effective healthcare products that address large consumer markets. GelStat(TM) Arthritis is the Company's second product to utilize GelStat's patent-pending formulation and is provided as a daily use, sublingual dissolving tablet. The Company has also developed "GelStat(TM) Sleep," and feedback from test samples have led us to believe that it performs well and is effective for its intended use For more information please visit www.gelstat.com

Click the following links to access WSR's financial reports:

•GelStat Corporate Fact Sheet 8/22/08

Additional Information:

•Informative video on GelStat Migraine

•Clinical Study on GelStat Migraine

•GelStat's Investor Relations Web Pages

***Stay up to date with current events by joining GelStat's email alert list. Join by clicking the following link: (GelStat's Email Alert) ***